Is Nemaura Medical Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Nemaura Medical Inc (NMRD) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nemaura Medical Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nemaura Medical Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Nemaura Medical Inc?

Muslim investors may consider investing in Nemaura Medical Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nemaura Medical Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Nemaura Medical Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nemaura Medical Inc updated?

The Shariah compliance status of Nemaura Medical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nemaura Medical Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nemaura Medical Inc?

You can check the latest Shariah compliance status of Nemaura Medical Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NMRD Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 27, 2024

Report Source: 2024 3rd Quarter Report

Analyst's Ratings for Nemaura Medical Inc (NMRD)

Based on 7 analysts giving stock ratings to Nemaura Medical Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Nemaura Medical Inc. Stock Analysis NMRD

United States Health Care Nano Cap Report: Q3, 2024

Nemaura Medical, Inc. operates as a holding company. The company is headquartered in Manhattan, New York and currently employs 36 full-time employees. The company went IPO on 2014-11-04. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients and support obesity and weight-loss programs. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The Company’s applications of its technology include glucose monitoring, temperature monitoring, lactate monitoring, alcohol monitoring, and substance abuse monitoring. Its platform uses precision microsystems-based technology.

Key Statistics of Nemaura Medical Inc (NMRD)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

216.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.05

Market Cap

4035.00

Avg. Volume

2909.50

Dividend Yield

Financial Metrics & Statements of Nemaura Medical Inc (NMRD)

FAQ's for Nemaura Medical Inc (NMRD)

According to Musaffa’s Shariah screening methodology, Nemaura Medical Inc (NMRD) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.